Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $28.69 Average Price Target from Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have earned a consensus rating of “Hold” from the fifteen analysts that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $29.8462.

Several equities analysts recently weighed in on the stock. UBS Group raised their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Guggenheim increased their price objective on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a report on Thursday. TD Cowen raised their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Barclays lifted their target price on Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a report on Thursday. Finally, Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the stock from $24.50 to $30.00 in a research report on Wednesday, June 3rd.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Goldman Sachs Group Inc. grew its holdings in shares of Acadia Healthcare by 417.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after purchasing an additional 3,815,471 shares in the last quarter. Jefferies Financial Group Inc. purchased a new stake in Acadia Healthcare during the fourth quarter valued at $47,960,000. Wellington Management Group LLP raised its stake in Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares in the last quarter. Vaughan Nelson Investment Management L.P. bought a new position in Acadia Healthcare during the first quarter valued at $43,017,000. Finally, Invenomic Capital Management LP grew its stake in shares of Acadia Healthcare by 71.0% in the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock worth $46,998,000 after buying an additional 1,375,647 shares in the last quarter.

Acadia Healthcare Trading Up 5.3%

ACHC stock opened at $29.62 on Friday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.71. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $35.83. The business has a 50 day simple moving average of $28.23 and a two-hundred day simple moving average of $23.74. The company has a market capitalization of $2.76 billion, a price-to-earnings ratio of -2.38, a PEG ratio of 9.35 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. During the same quarter last year, the business posted $0.83 earnings per share. The company’s revenue for the quarter was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Research analysts anticipate that Acadia Healthcare will post 1.51 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.